Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Intuit Inc. (INTU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Intuit Inc. — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Intuit Inc. trades at $312.3 (market cap $82.96B). The key difference: Intuit Inc. is far larger — about 2.7× GE HealthCare Technologies Inc. Common Stock's market cap, and Intuit Inc. pays the higher dividend (1.78%). Which is the better fit depends on your goals.
| GEHC | INTU | |
|---|---|---|
Market Cap | $30.93B | $82.96B |
Volume | 5,033,451 | 2,923,762 |
Sector | Health | Technology |
52-Week High | $88.16 | $683.39 |
52-Week Low | $59.48 | $255.07 |
Enterprise Value | $39.39B | $84.18B |
Dividend Yield | 0.23% | 1.78% |
Typical Hold Time | — | 67 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Intuit (INTU) trades at $301.45, down 1.48% today, with strong fundamentals including 21.3% net income margin and consistent earnings beats. The stock shows bullish technical signals with support at $302 and resistance at $312. Revenue growth accelerated to $18.8B in 2025, while analyst consensus remains positive with a $379.68 price target. Recent news highlights class action lawsuits but also emphasizes growth in QuickBooks monetization and AI initiatives.
INTU presents a compelling growth story with robust profitability and analyst support, though legal overhangs and valuation near 52-week highs warrant caution. The company's focus on AI and new customer acquisition provides upside potential, but investors should monitor lawsuit developments and competitive pressures in the financial software sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Intuit Inc.
Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of U.S. market share for small-business accounting and DIY tax-filing software.
Read more on INTU →
